{
    "xml": "<topic id=\"PHP2967\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/rufinamide\" basename=\"rufinamide\" title=\"RUFINAMIDE\">\n<title>RUFINAMIDE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_1102\" namespace=\"/interactions/list-of-drug-interactions/antiepileptics/rufinamide\">Rufinamide</xref>\n</p>\n<data name=\"vtmid\">429802008</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_926692410\" title=\"Antiepileptics\">Antiepileptics</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP71362\" outputclass=\"indicationsAndDose\" rev=\"1.64\" parent=\"/drugs/rufinamide\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Adjunctive treatment of seizures in Lennox-Gastaut syndrome</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 4&#8211;17 years (body-weight up to 30 kg)</p>\n<p>Initially 100&#8239;mg twice daily, then increased in steps of 100&#8239;mg twice daily (max. per dose 500&#8239;mg twice daily), adjusted according to response, dose to be increased at intervals of not less than 2 days.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 4&#8211;17 years (body-weight 30&#8211;50 kg)</p>\n<p>Initially 200&#8239;mg twice daily, then increased in steps of 200&#8239;mg twice daily (max. per dose 900&#8239;mg twice daily), adjusted according to response, dose to be increased at intervals of not less than 2 days.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult (body-weight 30&#8211;50 kg)</p>\n<p>Initially 200&#8239;mg twice daily, then increased in steps of 200&#8239;mg twice daily (max. per dose 900&#8239;mg twice daily), adjusted according to response, dose to be increased at intervals of not less than 2 days.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 4&#8211;17 years (body-weight 50&#8211;70 kg)</p>\n<p>Initially 200&#8239;mg twice daily, then increased in steps of 200&#8239;mg twice daily (max. per dose 1.2&#8239;g twice daily), adjusted according to response, dose to be increased at intervals of not less than 2 days.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult (body-weight 50&#8211;70 kg)</p>\n<p>Initially 200&#8239;mg twice daily, then increased in steps of 200&#8239;mg twice daily (max. per dose 1.2&#8239;g twice daily), adjusted according to response, dose to be increased at intervals of not less than 2 days.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult (body-weight 70 kg and above)</p>\n<p>Initially 200&#8239;mg twice daily, then increased in steps of 200&#8239;mg twice daily (max. per dose 1.6&#8239;g twice daily), adjusted according to response, dose to be increased at intervals of not less than 2 days.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Adjunctive treatment of seizures in Lennox-Gastaut syndrome with valproate</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 4&#8211;17 years (body-weight up to 30 kg)</p>\n<p>Initially 100&#8239;mg twice daily, then increased in steps of 100&#8239;mg twice daily (max. per dose 300&#8239;mg twice daily), adjusted according to response, dose to be increased at intervals of not less than 2 days.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP71358\" outputclass=\"interactions\" rev=\"1.13\" parent=\"/drugs/rufinamide\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (rufinamide).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP71311\" outputclass=\"sideEffects\" rev=\"1.11\" parent=\"/drugs/rufinamide\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Abdominal pain</ph>; <ph outputclass=\"sideEffect\">acne</ph>; <ph outputclass=\"sideEffect\">anorexia</ph>; <ph outputclass=\"sideEffect\">anxiety</ph>; <ph outputclass=\"sideEffect\">back pain</ph>; <ph outputclass=\"sideEffect\">blurred vision</ph>; <ph outputclass=\"sideEffect\">constipation</ph>; <ph outputclass=\"sideEffect\">diarrhoea</ph>; <ph outputclass=\"sideEffect\">diplopia</ph>; <ph outputclass=\"sideEffect\">dizziness</ph>; <ph outputclass=\"sideEffect\">drowsiness</ph>; <ph outputclass=\"sideEffect\">dyspepsia</ph>; <ph outputclass=\"sideEffect\">epistaxis</ph>; <ph outputclass=\"sideEffect\">fatigue</ph>; <ph outputclass=\"sideEffect\">gait disturbances</ph>; <ph outputclass=\"sideEffect\">headache</ph>; <ph outputclass=\"sideEffect\">hyperactivity</ph>; <ph outputclass=\"sideEffect\">hypersensitivity syndrome</ph>; <ph outputclass=\"sideEffect\">impaired coordination</ph>; <ph outputclass=\"sideEffect\">increase in seizure frequency</ph>; <ph outputclass=\"sideEffect\">influenza-like symptoms</ph>; <ph outputclass=\"sideEffect\">insomnia</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">nystagmus</ph>; <ph outputclass=\"sideEffect\">oligomenorrhoea</ph>; <ph outputclass=\"sideEffect\">rash</ph>; <ph outputclass=\"sideEffect\">rhinitis</ph>; <ph outputclass=\"sideEffect\">tremor</ph>; <ph outputclass=\"sideEffect\">vomiting</ph>; <ph outputclass=\"sideEffect\">weight loss</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP71486\" outputclass=\"allergyAndCrossSensitivity\" rev=\"1.22\" parent=\"/drugs/rufinamide\">\n<title>Allergy and cross-sensitivity</title>\n<body>\r\n\r\n<section outputclass=\"allergyAndCrossSensitivityCrossSensitivity\">\r\n<sectiondiv>\r\n<p>Antiepileptic hypersensitivity syndrome associated with rufinamide. See under <xref format=\"dita\" href=\"#PHP78230\" type=\"bookmark\" namespace=\"/treatment-summaries/epilepsy\">Epilepsy</xref> for more information.</p>\n</sectiondiv>\n</section>\r\n</body>\n</topic>\n<topic id=\"PHP71469\" outputclass=\"breastFeeding\" parent=\"/drugs/rufinamide\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises avoid&#8212;no information available.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP71392\" outputclass=\"hepaticImpairment\" parent=\"/drugs/rufinamide\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p>Caution and careful dose titration in mild to moderate impairment.</p>\n</sectiondiv>\n</section>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid in severe impairment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP71497\" outputclass=\"directionsForAdministration\" rev=\"1.9\" parent=\"/drugs/rufinamide\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">In children</p>\n<p>Tablets may be crushed and given in half a glass of water.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP57726\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.10\" parent=\"/drugs/rufinamide\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"title\">Switching between formulations</p>\n<p>Care should be taken when switching between oral formulations. The need for continued supply of a particular manufacturer's product should be based on clinical judgement and consultation with the patient or their carer, taking into account factors such as seizure frequency and treatment history.</p>\n<p>Patients may need to be maintained on a specific manufacturer&#8217;s branded or generic rufinamide product.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP71347\" outputclass=\"patientAndCarerAdvice\" rev=\"1.19\" parent=\"/drugs/rufinamide\">\n<title>Patient and carer advice</title>\n<body>\r\n\r\n\r\n<section outputclass=\"patientResources\">\r\n<sectiondiv>\r\n<p outputclass=\"specificity\">In children</p>\r\n<p outputclass=\"title\">Medicines for Children leaflet: Rufinamide for preventing seizures</p>\r\n<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/rufinamide-for-preventing-seizures\">www.medicinesforchildren.org.uk/rufinamide-for-preventing-seizures</xref>\n</p>\n</sectiondiv>\n</section>\r\n<section outputclass=\"generalPatientAdvice\">\r\n<sectiondiv>\r\n<p>Counselling on antiepileptic hypersensitivity syndrome is advised.</p>\n</sectiondiv>\n</section>\r\n\r\n\r\n\r\n\r\n\r\n</body>\n</topic>\n<topic id=\"PHP71241\" outputclass=\"nationalFunding\" rev=\"1.13\" parent=\"/drugs/rufinamide\">\n<title>National funding/access decisions</title>\n<body>\n<section>\n<sectiondiv outputclass=\"smcDecisions\">\n<p outputclass=\"title\">Scottish Medicines Consortium (SMC) Decisions</p>\n<sectiondiv outputclass=\"smcDecision\">\n<sectiondiv>\n<p>The <i>Scottish Medicines Consortium</i> has advised (October 2008) that rufinamide (<i>Inovelon</i>\n<tm tmtype=\"reg\"/>) is accepted for restricted use within NHS Scotland as adjunctive therapy in the treatment of seizures associated with Lennox-Gastaut syndrome in patients 4 years and above. It is restricted for use when alternative traditional antiepileptic drugs are unsatisfactory.</p>\n</sectiondiv>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP2967-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/rufinamide\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76195\" title=\"Tablet\" namespace=\"/drugs/rufinamide/tablet\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76202\" title=\"Oral suspension\" namespace=\"/drugs/rufinamide/oral-suspension\">Oral suspension</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_1102\" namespace=\"/interactions/list-of-drug-interactions/antiepileptics/rufinamide\" title=\"Rufinamide\" count=\"1\" rel=\"link\">Rufinamide</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78230\" namespace=\"/treatment-summaries/epilepsy\" title=\"Epilepsy\" count=\"1\" rel=\"link\">Epilepsy</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76195\" namespace=\"/drugs/rufinamide/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76202\" namespace=\"/drugs/rufinamide/oral-suspension\" title=\"Oral suspension\" count=\"1\" rel=\"link\">Oral suspension</xref>\n</links>\n</topic>",
    "id": "PHP2967",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/rufinamide",
    "basename": "rufinamide",
    "title": "RUFINAMIDE",
    "interactants": [
        {
            "id": "bnf_int_1102",
            "label": "Rufinamide"
        }
    ],
    "vtmid": "429802008",
    "drugClassification": [
        "Antiepileptics"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Adjunctive treatment of seizures in Lennox-Gastaut syndrome",
                        "html": "Adjunctive treatment of seizures in Lennox-Gastaut syndrome"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "child": [
                    {
                        "textContent": "Initially 100 mg twice daily, then increased in steps of 100 mg twice daily (max. per dose 500 mg twice daily), adjusted according to response, dose to be increased at intervals of not less than 2 days.",
                        "html": "<p>Initially 100&#8239;mg twice daily, then increased in steps of 100&#8239;mg twice daily (max. per dose 500&#8239;mg twice daily), adjusted according to response, dose to be increased at intervals of not less than 2 days.</p>",
                        "ageGroup": "4&#8211;17 years (body-weight up to 30 kg)"
                    },
                    {
                        "textContent": "Initially 200 mg twice daily, then increased in steps of 200 mg twice daily (max. per dose 900 mg twice daily), adjusted according to response, dose to be increased at intervals of not less than 2 days.",
                        "html": "<p>Initially 200&#8239;mg twice daily, then increased in steps of 200&#8239;mg twice daily (max. per dose 900&#8239;mg twice daily), adjusted according to response, dose to be increased at intervals of not less than 2 days.</p>",
                        "ageGroup": "4&#8211;17 years (body-weight 30&#8211;50 kg)"
                    },
                    {
                        "textContent": "Initially 200 mg twice daily, then increased in steps of 200 mg twice daily (max. per dose 1.2 g twice daily), adjusted according to response, dose to be increased at intervals of not less than 2 days.",
                        "html": "<p>Initially 200&#8239;mg twice daily, then increased in steps of 200&#8239;mg twice daily (max. per dose 1.2&#8239;g twice daily), adjusted according to response, dose to be increased at intervals of not less than 2 days.</p>",
                        "ageGroup": "4&#8211;17 years (body-weight 50&#8211;70 kg)"
                    }
                ],
                "adult": [
                    {
                        "textContent": "Initially 200 mg twice daily, then increased in steps of 200 mg twice daily (max. per dose 900 mg twice daily), adjusted according to response, dose to be increased at intervals of not less than 2 days.",
                        "html": "<p>Initially 200&#8239;mg twice daily, then increased in steps of 200&#8239;mg twice daily (max. per dose 900&#8239;mg twice daily), adjusted according to response, dose to be increased at intervals of not less than 2 days.</p>",
                        "ageGroup": "(body-weight 30&#8211;50 kg)"
                    },
                    {
                        "textContent": "Initially 200 mg twice daily, then increased in steps of 200 mg twice daily (max. per dose 1.2 g twice daily), adjusted according to response, dose to be increased at intervals of not less than 2 days.",
                        "html": "<p>Initially 200&#8239;mg twice daily, then increased in steps of 200&#8239;mg twice daily (max. per dose 1.2&#8239;g twice daily), adjusted according to response, dose to be increased at intervals of not less than 2 days.</p>",
                        "ageGroup": "(body-weight 50&#8211;70 kg)"
                    },
                    {
                        "textContent": "Initially 200 mg twice daily, then increased in steps of 200 mg twice daily (max. per dose 1.6 g twice daily), adjusted according to response, dose to be increased at intervals of not less than 2 days.",
                        "html": "<p>Initially 200&#8239;mg twice daily, then increased in steps of 200&#8239;mg twice daily (max. per dose 1.6&#8239;g twice daily), adjusted according to response, dose to be increased at intervals of not less than 2 days.</p>",
                        "ageGroup": "(body-weight 70 kg and above)"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Adjunctive treatment of seizures in Lennox-Gastaut syndrome with valproate",
                        "html": "Adjunctive treatment of seizures in Lennox-Gastaut syndrome with valproate"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "child": [
                    {
                        "textContent": "Initially 100 mg twice daily, then increased in steps of 100 mg twice daily (max. per dose 300 mg twice daily), adjusted according to response, dose to be increased at intervals of not less than 2 days.",
                        "html": "<p>Initially 100&#8239;mg twice daily, then increased in steps of 100&#8239;mg twice daily (max. per dose 300&#8239;mg twice daily), adjusted according to response, dose to be increased at intervals of not less than 2 days.</p>",
                        "ageGroup": "4&#8211;17 years (body-weight up to 30 kg)"
                    }
                ]
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (rufinamide).",
                "html": "<p>Appendix 1 (rufinamide).</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Abdominal pain",
                        "html": "Abdominal pain",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "acne",
                        "html": "acne",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "anorexia",
                        "html": "anorexia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "anxiety",
                        "html": "anxiety",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "back pain",
                        "html": "back pain",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "blurred vision",
                        "html": "blurred vision",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "constipation",
                        "html": "constipation",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "diarrhoea",
                        "html": "diarrhoea",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "diplopia",
                        "html": "diplopia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "dizziness",
                        "html": "dizziness",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "drowsiness",
                        "html": "drowsiness",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "dyspepsia",
                        "html": "dyspepsia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "epistaxis",
                        "html": "epistaxis",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "fatigue",
                        "html": "fatigue",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "gait disturbances",
                        "html": "gait disturbances",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "headache",
                        "html": "headache",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "hyperactivity",
                        "html": "hyperactivity",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "hypersensitivity syndrome",
                        "html": "hypersensitivity syndrome",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "impaired coordination",
                        "html": "impaired coordination",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "increase in seizure frequency",
                        "html": "increase in seizure frequency",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "influenza-like symptoms",
                        "html": "influenza-like symptoms",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "insomnia",
                        "html": "insomnia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "nystagmus",
                        "html": "nystagmus",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "oligomenorrhoea",
                        "html": "oligomenorrhoea",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "rash",
                        "html": "rash",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "rhinitis",
                        "html": "rhinitis",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "tremor",
                        "html": "tremor",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "vomiting",
                        "html": "vomiting",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "weight loss",
                        "html": "weight loss",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        }
    },
    "allergyAndCrossSensitivity": {
        "crossSensitivity": [
            {
                "type": "crossSensitivity",
                "references": [
                    {
                        "id": "PHP78230",
                        "label": "Epilepsy"
                    }
                ],
                "textContent": "Antiepileptic hypersensitivity syndrome associated with rufinamide. See under Epilepsy for more information.",
                "html": "<p>Antiepileptic hypersensitivity syndrome associated with rufinamide. See under <xref format=\"dita\" href=\"#PHP78230\" type=\"bookmark\" namespace=\"/treatment-summaries/epilepsy\">Epilepsy</xref> for more information.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises avoid&#8212;no information available.",
                "html": "<p>Manufacturer advises avoid&#8212;no information available.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "textContent": "Caution and careful dose titration in mild to moderate impairment.",
                "html": "<p>Caution and careful dose titration in mild to moderate impairment.</p>"
            }
        ],
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid in severe impairment.",
                "html": "<p>Avoid in severe impairment.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "textContent": "Tablets may be crushed and given in half a glass of water.",
                "html": "<p>Tablets may be crushed and given in half a glass of water.</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "title": "Switching between formulations",
                "textContent": "Care should be taken when switching between oral formulations. The need for continued supply of a particular manufacturer's product should be based on clinical judgement and consultation with the patient or their carer, taking into account factors such as seizure frequency and treatment history.\n\nPatients may need to be maintained on a specific manufacturer&#8217;s branded or generic rufinamide product.",
                "html": "<p>Care should be taken when switching between oral formulations. The need for continued supply of a particular manufacturer's product should be based on clinical judgement and consultation with the patient or their carer, taking into account factors such as seizure frequency and treatment history.</p><p>Patients may need to be maintained on a specific manufacturer&#8217;s branded or generic rufinamide product.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "patientResources": [
            {
                "type": "patientResources",
                "references": [
                    {
                        "id": "http://www.medicinesforchildren.org.uk/rufinamide-for-preventing-seizures",
                        "label": "www.medicinesforchildren.org.uk/rufinamide-for-preventing-seizures"
                    }
                ],
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "title": "Medicines for Children leaflet: Rufinamide for preventing seizures",
                "textContent": "www.medicinesforchildren.org.uk/rufinamide-for-preventing-seizures",
                "html": "<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/rufinamide-for-preventing-seizures\">www.medicinesforchildren.org.uk/rufinamide-for-preventing-seizures</xref>\n</p>"
            }
        ],
        "generalPatientAdvice": [
            {
                "type": "generalPatientAdvice",
                "textContent": "Counselling on antiepileptic hypersensitivity syndrome is advised.",
                "html": "<p>Counselling on antiepileptic hypersensitivity syndrome is advised.</p>"
            }
        ]
    },
    "nationalFunding": {
        "smcDecisions": [
            {
                "type": "smcDecisions",
                "textContent": "The Scottish Medicines Consortium has advised (October 2008) that rufinamide (Inovelon ) is accepted for restricted use within NHS Scotland as adjunctive therapy in the treatment of seizures associated with Lennox-Gastaut syndrome in patients 4 years and above. It is restricted for use when alternative traditional antiepileptic drugs are unsatisfactory.",
                "html": "<p>The <i>Scottish Medicines Consortium</i> has advised (October 2008) that rufinamide (<i>Inovelon</i> <tm tmtype=\"reg\"/>) is accepted for restricted use within NHS Scotland as adjunctive therapy in the treatment of seizures associated with Lennox-Gastaut syndrome in patients 4 years and above. It is restricted for use when alternative traditional antiepileptic drugs are unsatisfactory.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP76195",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76202",
                "label": "Oral suspension",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_1102",
                "label": "Rufinamide",
                "type": "interaction"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78230",
                "label": "Epilepsy",
                "type": "treatmentSummary"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP76195",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76202",
                "label": "Oral suspension",
                "type": "medicinalForm"
            }
        ]
    }
}